{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"MSH2 is a tumor suppressor involved in DNA mismatch repair. Select mutations of MSH2 are associated with Lynch syndrome and can lead to genomic instability in tumors.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"08/25/2017",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "8592341",
        "11257106",
        "23391514",
        "15528792",
        "24362816",
        "10946232",
        "7726159",
        "8566964"
      ]
    },
    "description":"Truncating mutations in MSH2 have been identified in individuals with Lynch syndrome and lead to the loss of normal mismatch repair function (PMID: 7726159, 8566964, 8592341, 15528792, 11257106, 24362816). These mutations disrupt the mismatch repair pathway due to partial or whole loss of the MutS domain necessary for the protein's function (PMID: 15528792, 10946232). Mutations causing loss of any domain of MSH2 are likely to disrupt its normal function since the N-terminal domain in required for its binding to mismatched nucleotides in DNA and, additionally, the C-terminal domain is necessary for dimerization, which in its turn is required for normal function (PMID: 23391514).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"V63*",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":4436,
    "hgvs":null,
    "hugoSymbol":"MSH2",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The MSH2 V63* mutation is likely oncogenic.",
  "vus":false
}